Journal article

Characteristics associated with anti-osteoporosis medication use: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Guggina, P., Flahive, J., Hooven, F., Watts, N., Siris, E., Silverman, S., Roux, C., Pfeilschifter, J., Greenspan, S., Díez-Pérez, A., Cooper, C., Compston, J., Chapurlat, R., Boonen, S., Adachi, J., Anderson, F., & Gehlbach, S. (2012). Characteristics associated with anti-osteoporosis medication use: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort. Bone.

MLA Style

Guggina, P., et al. “Characteristics Associated with Anti-Osteoporosis Medication Use: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA Cohort.” Bone, 2012.

Chicago Style

Guggina, P, J Flahive, F Hooven, N Watts, E Siris, S Silverman, C Roux, et al. 2012. “Characteristics Associated with Anti-Osteoporosis Medication Use: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA Cohort.” Bone.
Share
Print

Authors

+ Guggina, P More by this author

Role:: Author

+ Flahive, J More by this author

Role:: Author

+ Hooven, F More by this author

Role:: Author

+ Watts, N More by this author

Role:: Author

+ Siris, E More by this author

Role:: Author

More authors...

Journal:: Bone More from this journal
Publication date:: 2012-01-01
ISSN:: 8756-3282

Pubs id:: pubs:400764
UUID:: uuid:388d9405-ff17-4795-8b21-3672027afcbe
Local pid:: pubs:400764
Source identifiers:: 400764
Deposit date:: 2013-11-17

Terms of use

Copyright date:: 2012

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP